A randomized, double-blind study of the effect of Avastin plus cisplatin and gemcitabine or placebo plus cisplatin and gemcitabine on progression-free survival in treatment-naive patients with advanced or recurrent non-squamous NSCLC.
Phase of Trial: Phase III
Latest Information Update: 07 Jul 2015
At a glance
- Drugs Bevacizumab (Primary) ; Cisplatin; Gemcitabine
- Indications Non-small cell lung cancer; Squamous cell cancer
- Focus Registrational; Therapeutic Use
- Acronyms AVAiL
- Sponsors Roche
- 07 Jun 2011 New source identified and integrated (European Clinical Trials Database).
- 11 Feb 2010 Final analysis published in the Annals of Oncology.
- 30 May 2009 Final tolerability data presented at the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO-2009).
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History